Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status

Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opini...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Antonio Greco, Davide Capodanno
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/40721f3379a848deb4f209169266fe5f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:40721f3379a848deb4f209169266fe5f
record_format	dspace
spelling	oai:doaj.org-article:40721f3379a848deb4f209169266fe5f2021-12-04T16:02:41ZAnticoagulation after Transcatheter Aortic Valve Implantation: Current Status10.15420/icr.2019.241756-14851756-1477https://doaj.org/article/40721f3379a848deb4f209169266fe5f2020-04-01T00:00:00Zhttps://www.icrjournal.com/articleindex/icr.2019.24https://doaj.org/toc/1756-1477https://doaj.org/toc/1756-1485Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opinion and therefore yield low-grade recommendations. The optimal antithrombotic regimen following TAVI has yet to be determined and several randomised controlled trials assessing this issue are ongoing. The purpose of this article is to critically explore the impact of antithrombotic drugs, especially anticoagulants, on long-term clinical outcomes following successful TAVI.Antonio GrecoDavide CapodannoRadcliffe Medical MediaarticleSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENInterventional Cardiology: Reviews, Research, Resources, Vol 15, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Antonio Greco Davide Capodanno Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
description	Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opinion and therefore yield low-grade recommendations. The optimal antithrombotic regimen following TAVI has yet to be determined and several randomised controlled trials assessing this issue are ongoing. The purpose of this article is to critically explore the impact of antithrombotic drugs, especially anticoagulants, on long-term clinical outcomes following successful TAVI.
format	article
author	Antonio Greco Davide Capodanno
author_facet	Antonio Greco Davide Capodanno
author_sort	Antonio Greco
title	Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
title_short	Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
title_full	Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
title_fullStr	Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
title_full_unstemmed	Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
title_sort	anticoagulation after transcatheter aortic valve implantation: current status
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/40721f3379a848deb4f209169266fe5f
work_keys_str_mv	AT antoniogreco anticoagulationaftertranscatheteraorticvalveimplantationcurrentstatus AT davidecapodanno anticoagulationaftertranscatheteraorticvalveimplantationcurrentstatus
_version_	1718372729105678336

Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status

Ejemplares similares